Sickle Cell Disease Market - Expected to Rise at a Remarkable CAGR By 2025
Precisemarketreports.com adds new report “Sickle Cell Disease - Market Insights, Epidemiology and Market Forecast – 2025” which contains global key player’s survey information and forecast to 2022.
(EMAILWIRE.COM, November 19, 2017 ) Market Scenario:
According to top market research analysts, the Sickle Cell Disease market to grow steadily at a CAGR of 0.85% from 2015-2025 in 6MM (excluding Japan). United States contributes the major share of Sickle Cell Disease market as compared to EU5 countries. The therapeutic market of Sickle Cell Disease in 6MM is expected to reach USD 3.1 Billion in 2025 at the good CAGR value from 2015-2025. The higher prevalence of Sickle Cell Disease in United States is attributed to the immigration of majority of African population in the United States.
The “Sickle Cell Disease (SCD) – Market Insights, Epidemiology and Market Forecast-2025” report provides an overview of Sickle Cell Disease, epidemiology and market trends of the Sickle Cell Disease for the United States and EU5 (Germany, Spain, Italy, France and United Kingdom). The Report covers the therapeutics market revenue, treatment practice/algorithm and forecasted market size of Sickle Cell Disease from 2017 to 2025 segmented by seven major markets. In addition, the report also includes the forecasted epidemiology of Sickle Cell Disease till 2025.The Report also covers market drivers, market barriers and unmet medical need.
Get a Sample Copy of this Report @
https://www.precisemarketreports.com/report/sample/pmr-62722 .
Greater uptake by the three emerging novel drugs Endari (Emmaus Lifesciences), GBT-440 (GBT Therapeutics), and Crizanlizumab (Novartis) will primarily drive the SCD market. As the number of effective treatments for the Sickle Cell Disease increase in the market during the forecast period, the prescription medications (HU; Iron Chelators, Analegesics, Antibiotics, vaccines) market share will start to decrease. Emmaus’s Endari will be the preferred therapy for the complications associated with SCD owing to its less cost, which will give more patient access to this therapy.
Get a 20% Discount on Single User report spread across 105 pages @
https://www.precisemarketreports.com/report/discount/pmr-62722 .
Key Coverage and Benefits:
1. The report will help in developing business strategies by understanding the trends shaping and driving the global Sickle Cell Disease market.
2. Organize sales and marketing efforts by identifying the best opportunities for Sickle Cell Disease in US and European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom).
3. To understand the future market competition in the Sickle Cell Disease market and Insightful review of the key market drivers and barriers.
4. The report provides historical as well as forecasted epidemiology of Sickle Cell Disease in the 6MM covering United States and EU5 (Germany, Spain, Italy, France and United Kingdom) from 2015-2025.
5. The Report also covers the detailed historical and forecasted Sickle Cell Disease market covering United States and European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) from 2015-2025.
To know more click here ->
https://www.precisemarketreports.com/report/enquiry/pmr-62722 .
Major Points in Table of Contents:
Global Sickle Cell Disease Market Report 2017
1. Report Summary
2. Sickle Cell Disease Market Overview at a Glance
3. Disease Background and Overview: Sickle Cell Disease
4. Epidemiology and Patient Population
5. Prevalent Population of Sickle Cell Disease in 6MM
6. Epidemiology of Sickle Cell Disease
7. United States
7.1. Assumptions and Rationale
7.2. Prevalent Population of Sickle Cell Disease in United States
…………..Continue.
15. Specific pain management
16. Supportive care: Oxygen therapy
17. Hydration: Fluid replacement
18. Antibiotics
19. Transfusions
20. First line treatment
21. Hydroxyurea
22. Bone marrow transplantation
23. Current Unmet needs
24. Marketed Drugs for Sickle Cell Disease
25. Emerging Drugs for Sickle Cell Disease
26. Failed Therapies
27. Sickle Cell Disease (SCD): Market Analysis
28. United States
28.1. Market Size of Sickle Cell Disease (SCD) in United States
…………..Continue.
35. Market Drivers
36. Market Barriers
37. Appendix
38. Report Methodology
39. Consulting Services
40. Disclaimer
41. About DelveInsight
About us:
Precise market reports, a one-stop research platform designed to help key decision makers and dynamic thought leaders across various industry verticals worldwide by making them aware of the past, current and future market scenario.
Tier 1's, SME's startups, top management consultants, have clearly visualized their environment using our analysis, thus enabling them to make critical business decisions and in devising a strategic plan.
Contact us:
Precise Market Reports
Office No. 48, Akshya Complex, Dhole Patil road,
Maharashtra, Pune – 411001
India.
sales@precisemarketreports.com
+1 (323) 744 6588
https://www.precisemarketreports.com
According to top market research analysts, the Sickle Cell Disease market to grow steadily at a CAGR of 0.85% from 2015-2025 in 6MM (excluding Japan). United States contributes the major share of Sickle Cell Disease market as compared to EU5 countries. The therapeutic market of Sickle Cell Disease in 6MM is expected to reach USD 3.1 Billion in 2025 at the good CAGR value from 2015-2025. The higher prevalence of Sickle Cell Disease in United States is attributed to the immigration of majority of African population in the United States.
The “Sickle Cell Disease (SCD) – Market Insights, Epidemiology and Market Forecast-2025” report provides an overview of Sickle Cell Disease, epidemiology and market trends of the Sickle Cell Disease for the United States and EU5 (Germany, Spain, Italy, France and United Kingdom). The Report covers the therapeutics market revenue, treatment practice/algorithm and forecasted market size of Sickle Cell Disease from 2017 to 2025 segmented by seven major markets. In addition, the report also includes the forecasted epidemiology of Sickle Cell Disease till 2025.The Report also covers market drivers, market barriers and unmet medical need.
Get a Sample Copy of this Report @
https://www.precisemarketreports.com/report/sample/pmr-62722 .
Greater uptake by the three emerging novel drugs Endari (Emmaus Lifesciences), GBT-440 (GBT Therapeutics), and Crizanlizumab (Novartis) will primarily drive the SCD market. As the number of effective treatments for the Sickle Cell Disease increase in the market during the forecast period, the prescription medications (HU; Iron Chelators, Analegesics, Antibiotics, vaccines) market share will start to decrease. Emmaus’s Endari will be the preferred therapy for the complications associated with SCD owing to its less cost, which will give more patient access to this therapy.
Get a 20% Discount on Single User report spread across 105 pages @
https://www.precisemarketreports.com/report/discount/pmr-62722 .
Key Coverage and Benefits:
1. The report will help in developing business strategies by understanding the trends shaping and driving the global Sickle Cell Disease market.
2. Organize sales and marketing efforts by identifying the best opportunities for Sickle Cell Disease in US and European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom).
3. To understand the future market competition in the Sickle Cell Disease market and Insightful review of the key market drivers and barriers.
4. The report provides historical as well as forecasted epidemiology of Sickle Cell Disease in the 6MM covering United States and EU5 (Germany, Spain, Italy, France and United Kingdom) from 2015-2025.
5. The Report also covers the detailed historical and forecasted Sickle Cell Disease market covering United States and European Union 5 (EU5- Germany, Spain, Italy, France and United Kingdom) from 2015-2025.
To know more click here ->
https://www.precisemarketreports.com/report/enquiry/pmr-62722 .
Major Points in Table of Contents:
Global Sickle Cell Disease Market Report 2017
1. Report Summary
2. Sickle Cell Disease Market Overview at a Glance
3. Disease Background and Overview: Sickle Cell Disease
4. Epidemiology and Patient Population
5. Prevalent Population of Sickle Cell Disease in 6MM
6. Epidemiology of Sickle Cell Disease
7. United States
7.1. Assumptions and Rationale
7.2. Prevalent Population of Sickle Cell Disease in United States
…………..Continue.
15. Specific pain management
16. Supportive care: Oxygen therapy
17. Hydration: Fluid replacement
18. Antibiotics
19. Transfusions
20. First line treatment
21. Hydroxyurea
22. Bone marrow transplantation
23. Current Unmet needs
24. Marketed Drugs for Sickle Cell Disease
25. Emerging Drugs for Sickle Cell Disease
26. Failed Therapies
27. Sickle Cell Disease (SCD): Market Analysis
28. United States
28.1. Market Size of Sickle Cell Disease (SCD) in United States
…………..Continue.
35. Market Drivers
36. Market Barriers
37. Appendix
38. Report Methodology
39. Consulting Services
40. Disclaimer
41. About DelveInsight
About us:
Precise market reports, a one-stop research platform designed to help key decision makers and dynamic thought leaders across various industry verticals worldwide by making them aware of the past, current and future market scenario.
Tier 1's, SME's startups, top management consultants, have clearly visualized their environment using our analysis, thus enabling them to make critical business decisions and in devising a strategic plan.
Contact us:
Precise Market Reports
Office No. 48, Akshya Complex, Dhole Patil road,
Maharashtra, Pune – 411001
India.
sales@precisemarketreports.com
+1 (323) 744 6588
https://www.precisemarketreports.com
Contact Information:
Precise Market Reports
Parag Pingale
Tel: +1 (323) 744 6588
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Precise Market Reports
Parag Pingale
Tel: +1 (323) 744 6588
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results